HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth

Markus A. Queisser, Laura A. Dada, Nimrod Deiss-Yehiely, Martin Angulo, Guofei Zhou, Fotini M. Kouri, Lawrence M. Knab, Jing Liu, Alexander H. Stegh, Malcolm M. DeCamp, G. R.Scott Budinger, Navdeep S. Chandel, Aaron Ciechanover, Kazuhiro Iwai, Jacob I. Sznajder*

*Corresponding author for this work

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Rationale: Protein kinase C zeta (PKCζ) has been reported to act as a tumor suppressor. Deletion of PKCζ in experimental cancer models has been shown to increase tumor growth. However, the mechanisms of PKCζ down-regulation in cancerous cells have not been previously described. Objectives: To determine the molecular mechanisms that lead to decreased PKCζ expression and thus increased survival in cancer cells and tumor growth. Methods: The levels of expression of heme-oxidized IRP2 ubiquitin ligase 1L (HOIL-1L), HOIL-1 -interacting protein (HOIP), Shank-associated RH domain-interacting protein (SHARPIN), and PKCζ were analyzed by Western blot and/or quantitative real-time polymerase chain reaction in different cell lines. Coimmunoprecipitation experiments were used to demonstrate the interaction between HOIL-1L and PKCζ. Ubiquitination was measured in an in vitro ubiquitination assay and by Western blot with specific antibodies. The role of hypoxia-inducible factor (HIF) was determined by gain/loss-of-function experiments. The effect of HOIL-1L expression on cell death was investigated using RNA interference approaches in vitro and on tumor growth in mice models. Increased HOIL-1L and decreased PKCζ expression was assessed in lung adenocarcinoma and glioblastoma multiforme and documented in several other cancer types by oncogenomic analysis. Measurements and Main Results: Hypoxia is a hallmark of rapidly growing solid tumors.We found that during hypoxia, PKCζ is ubiquitinated and degraded via the ubiquitin ligase HOIL-1L, a component of the linear ubiquitin chain assembly complex (LUBAC). In vitro ubiquitination assays indicate that HOIL-1L ubiquitinates PKCζ at Lys-48, targeting it for proteasomal degradation. In a xenograft tumormodel and lung cancermodel, we found that silencing of HOIL-1L increased the abundance of PKCζ and decreased the size of tumors, suggesting that lower levels of HOIL-1L promote survival. Indeed, mRNA transcript levels of HOIL-1L were elevated in tumor of patients with lung adenocarcinoma, and in a lung adenocarcinoma tissue microarray the levels of HOIL-1L were associated with high-grade tumors. Moreover, we found that HOIL-1L expression was regulated by HIFs. Interestingly, the actions of HOIL-1L were independent of LUBAC. Conclusions: These data provide first evidence of a mechanism of cancer cell adaptation to hypoxia where HIFs regulate HOIL-1L, which targets PKCζ for degradation to promote tumor survival. We provided a proof of concept that silencing of HOIL-1L impairs lung tumor growth and that HOIL-1L expression predicts survival rate in cancer patients suggesting that HOIL-1L is an attractive target for cancer therapy.

Original languageEnglish (US)
Pages (from-to)688-698
Number of pages11
JournalAmerican journal of respiratory and critical care medicine
Volume190
Issue number6
DOIs
StatePublished - Sep 15 2014

Fingerprint

Ligases
Ubiquitin
Heme
Lung
Growth
Neoplasms
Ubiquitination
protein kinase C zeta
Western Blotting
Survival
Glioblastoma
RNA Interference

Keywords

  • E3 ligase
  • Hypoxia
  • Hypoxia-inducible factors
  • Linear ubiquitin chain assembly complex
  • Tumorigenesis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Queisser, Markus A. ; Dada, Laura A. ; Deiss-Yehiely, Nimrod ; Angulo, Martin ; Zhou, Guofei ; Kouri, Fotini M. ; Knab, Lawrence M. ; Liu, Jing ; Stegh, Alexander H. ; DeCamp, Malcolm M. ; Budinger, G. R.Scott ; Chandel, Navdeep S. ; Ciechanover, Aaron ; Iwai, Kazuhiro ; Sznajder, Jacob I. / HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth. In: American journal of respiratory and critical care medicine. 2014 ; Vol. 190, No. 6. pp. 688-698.
@article{5f1379a1f85049fda1cbcd2dbd7a8352,
title = "HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth",
abstract = "Rationale: Protein kinase C zeta (PKCζ) has been reported to act as a tumor suppressor. Deletion of PKCζ in experimental cancer models has been shown to increase tumor growth. However, the mechanisms of PKCζ down-regulation in cancerous cells have not been previously described. Objectives: To determine the molecular mechanisms that lead to decreased PKCζ expression and thus increased survival in cancer cells and tumor growth. Methods: The levels of expression of heme-oxidized IRP2 ubiquitin ligase 1L (HOIL-1L), HOIL-1 -interacting protein (HOIP), Shank-associated RH domain-interacting protein (SHARPIN), and PKCζ were analyzed by Western blot and/or quantitative real-time polymerase chain reaction in different cell lines. Coimmunoprecipitation experiments were used to demonstrate the interaction between HOIL-1L and PKCζ. Ubiquitination was measured in an in vitro ubiquitination assay and by Western blot with specific antibodies. The role of hypoxia-inducible factor (HIF) was determined by gain/loss-of-function experiments. The effect of HOIL-1L expression on cell death was investigated using RNA interference approaches in vitro and on tumor growth in mice models. Increased HOIL-1L and decreased PKCζ expression was assessed in lung adenocarcinoma and glioblastoma multiforme and documented in several other cancer types by oncogenomic analysis. Measurements and Main Results: Hypoxia is a hallmark of rapidly growing solid tumors.We found that during hypoxia, PKCζ is ubiquitinated and degraded via the ubiquitin ligase HOIL-1L, a component of the linear ubiquitin chain assembly complex (LUBAC). In vitro ubiquitination assays indicate that HOIL-1L ubiquitinates PKCζ at Lys-48, targeting it for proteasomal degradation. In a xenograft tumormodel and lung cancermodel, we found that silencing of HOIL-1L increased the abundance of PKCζ and decreased the size of tumors, suggesting that lower levels of HOIL-1L promote survival. Indeed, mRNA transcript levels of HOIL-1L were elevated in tumor of patients with lung adenocarcinoma, and in a lung adenocarcinoma tissue microarray the levels of HOIL-1L were associated with high-grade tumors. Moreover, we found that HOIL-1L expression was regulated by HIFs. Interestingly, the actions of HOIL-1L were independent of LUBAC. Conclusions: These data provide first evidence of a mechanism of cancer cell adaptation to hypoxia where HIFs regulate HOIL-1L, which targets PKCζ for degradation to promote tumor survival. We provided a proof of concept that silencing of HOIL-1L impairs lung tumor growth and that HOIL-1L expression predicts survival rate in cancer patients suggesting that HOIL-1L is an attractive target for cancer therapy.",
keywords = "E3 ligase, Hypoxia, Hypoxia-inducible factors, Linear ubiquitin chain assembly complex, Tumorigenesis",
author = "Queisser, {Markus A.} and Dada, {Laura A.} and Nimrod Deiss-Yehiely and Martin Angulo and Guofei Zhou and Kouri, {Fotini M.} and Knab, {Lawrence M.} and Jing Liu and Stegh, {Alexander H.} and DeCamp, {Malcolm M.} and Budinger, {G. R.Scott} and Chandel, {Navdeep S.} and Aaron Ciechanover and Kazuhiro Iwai and Sznajder, {Jacob I.}",
year = "2014",
month = "9",
day = "15",
doi = "10.1164/rccm.201403-0463OC",
language = "English (US)",
volume = "190",
pages = "688--698",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth. / Queisser, Markus A.; Dada, Laura A.; Deiss-Yehiely, Nimrod; Angulo, Martin; Zhou, Guofei; Kouri, Fotini M.; Knab, Lawrence M.; Liu, Jing; Stegh, Alexander H.; DeCamp, Malcolm M.; Budinger, G. R.Scott; Chandel, Navdeep S.; Ciechanover, Aaron; Iwai, Kazuhiro; Sznajder, Jacob I.

In: American journal of respiratory and critical care medicine, Vol. 190, No. 6, 15.09.2014, p. 688-698.

Research output: Contribution to journalArticle

TY - JOUR

T1 - HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth

AU - Queisser, Markus A.

AU - Dada, Laura A.

AU - Deiss-Yehiely, Nimrod

AU - Angulo, Martin

AU - Zhou, Guofei

AU - Kouri, Fotini M.

AU - Knab, Lawrence M.

AU - Liu, Jing

AU - Stegh, Alexander H.

AU - DeCamp, Malcolm M.

AU - Budinger, G. R.Scott

AU - Chandel, Navdeep S.

AU - Ciechanover, Aaron

AU - Iwai, Kazuhiro

AU - Sznajder, Jacob I.

PY - 2014/9/15

Y1 - 2014/9/15

N2 - Rationale: Protein kinase C zeta (PKCζ) has been reported to act as a tumor suppressor. Deletion of PKCζ in experimental cancer models has been shown to increase tumor growth. However, the mechanisms of PKCζ down-regulation in cancerous cells have not been previously described. Objectives: To determine the molecular mechanisms that lead to decreased PKCζ expression and thus increased survival in cancer cells and tumor growth. Methods: The levels of expression of heme-oxidized IRP2 ubiquitin ligase 1L (HOIL-1L), HOIL-1 -interacting protein (HOIP), Shank-associated RH domain-interacting protein (SHARPIN), and PKCζ were analyzed by Western blot and/or quantitative real-time polymerase chain reaction in different cell lines. Coimmunoprecipitation experiments were used to demonstrate the interaction between HOIL-1L and PKCζ. Ubiquitination was measured in an in vitro ubiquitination assay and by Western blot with specific antibodies. The role of hypoxia-inducible factor (HIF) was determined by gain/loss-of-function experiments. The effect of HOIL-1L expression on cell death was investigated using RNA interference approaches in vitro and on tumor growth in mice models. Increased HOIL-1L and decreased PKCζ expression was assessed in lung adenocarcinoma and glioblastoma multiforme and documented in several other cancer types by oncogenomic analysis. Measurements and Main Results: Hypoxia is a hallmark of rapidly growing solid tumors.We found that during hypoxia, PKCζ is ubiquitinated and degraded via the ubiquitin ligase HOIL-1L, a component of the linear ubiquitin chain assembly complex (LUBAC). In vitro ubiquitination assays indicate that HOIL-1L ubiquitinates PKCζ at Lys-48, targeting it for proteasomal degradation. In a xenograft tumormodel and lung cancermodel, we found that silencing of HOIL-1L increased the abundance of PKCζ and decreased the size of tumors, suggesting that lower levels of HOIL-1L promote survival. Indeed, mRNA transcript levels of HOIL-1L were elevated in tumor of patients with lung adenocarcinoma, and in a lung adenocarcinoma tissue microarray the levels of HOIL-1L were associated with high-grade tumors. Moreover, we found that HOIL-1L expression was regulated by HIFs. Interestingly, the actions of HOIL-1L were independent of LUBAC. Conclusions: These data provide first evidence of a mechanism of cancer cell adaptation to hypoxia where HIFs regulate HOIL-1L, which targets PKCζ for degradation to promote tumor survival. We provided a proof of concept that silencing of HOIL-1L impairs lung tumor growth and that HOIL-1L expression predicts survival rate in cancer patients suggesting that HOIL-1L is an attractive target for cancer therapy.

AB - Rationale: Protein kinase C zeta (PKCζ) has been reported to act as a tumor suppressor. Deletion of PKCζ in experimental cancer models has been shown to increase tumor growth. However, the mechanisms of PKCζ down-regulation in cancerous cells have not been previously described. Objectives: To determine the molecular mechanisms that lead to decreased PKCζ expression and thus increased survival in cancer cells and tumor growth. Methods: The levels of expression of heme-oxidized IRP2 ubiquitin ligase 1L (HOIL-1L), HOIL-1 -interacting protein (HOIP), Shank-associated RH domain-interacting protein (SHARPIN), and PKCζ were analyzed by Western blot and/or quantitative real-time polymerase chain reaction in different cell lines. Coimmunoprecipitation experiments were used to demonstrate the interaction between HOIL-1L and PKCζ. Ubiquitination was measured in an in vitro ubiquitination assay and by Western blot with specific antibodies. The role of hypoxia-inducible factor (HIF) was determined by gain/loss-of-function experiments. The effect of HOIL-1L expression on cell death was investigated using RNA interference approaches in vitro and on tumor growth in mice models. Increased HOIL-1L and decreased PKCζ expression was assessed in lung adenocarcinoma and glioblastoma multiforme and documented in several other cancer types by oncogenomic analysis. Measurements and Main Results: Hypoxia is a hallmark of rapidly growing solid tumors.We found that during hypoxia, PKCζ is ubiquitinated and degraded via the ubiquitin ligase HOIL-1L, a component of the linear ubiquitin chain assembly complex (LUBAC). In vitro ubiquitination assays indicate that HOIL-1L ubiquitinates PKCζ at Lys-48, targeting it for proteasomal degradation. In a xenograft tumormodel and lung cancermodel, we found that silencing of HOIL-1L increased the abundance of PKCζ and decreased the size of tumors, suggesting that lower levels of HOIL-1L promote survival. Indeed, mRNA transcript levels of HOIL-1L were elevated in tumor of patients with lung adenocarcinoma, and in a lung adenocarcinoma tissue microarray the levels of HOIL-1L were associated with high-grade tumors. Moreover, we found that HOIL-1L expression was regulated by HIFs. Interestingly, the actions of HOIL-1L were independent of LUBAC. Conclusions: These data provide first evidence of a mechanism of cancer cell adaptation to hypoxia where HIFs regulate HOIL-1L, which targets PKCζ for degradation to promote tumor survival. We provided a proof of concept that silencing of HOIL-1L impairs lung tumor growth and that HOIL-1L expression predicts survival rate in cancer patients suggesting that HOIL-1L is an attractive target for cancer therapy.

KW - E3 ligase

KW - Hypoxia

KW - Hypoxia-inducible factors

KW - Linear ubiquitin chain assembly complex

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84921646870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921646870&partnerID=8YFLogxK

U2 - 10.1164/rccm.201403-0463OC

DO - 10.1164/rccm.201403-0463OC

M3 - Article

C2 - 25118570

AN - SCOPUS:84921646870

VL - 190

SP - 688

EP - 698

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -